Episodic monocular vision loss after implantation of a vagal nerve stimulator

Annals of Internal Medicine

Volumn 155, Issue 9, 2011, Pages 648-649

  Sheck, Leo ^a   Meyer, Helen Danesh ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOBAZAM; LAMOTRIGINE; VALPROIC ACID;

ADOLESCENT; CASE REPORT; COLOR VISION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; EVENING DOSAGE; FEMALE; HUMAN; LETTER; MEDICAL INSTRUMENTATION; MORNING DOSAGE; OPHTHALMOSCOPY; PRIORITY JOURNAL; SEIZURE; SLIT LAMP; VAGUS NERVE STIMULATION; VAGUS NERVE STIMULATOR; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 80055086044     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-155-9-201111010-00022     Document Type: Letter

References (3)

1. Pati S, Alexopoulos AV. Pharmacoresistant epilepsy: from pathogenesis to current and emerging therapies. Cleve Clin J Med. 2010;77:457-67. [PMID: 20601619]
2. Hatton KW, McLarney JT, Pittman T, Fahy BG. Vagal nerve stimulation: overview and implications for anesthesiologists. Anesth Analg. 2006;103:1241-9. [PMID: 17056962]
3. Palanker D, Vankov A, Freyvert Y, Huie P. Pulsed electrical stimulation for control of vasculature: temporary vasoconstriction and permanent thrombosis. Bioelectromagnetics. 2008;29:100-7. [PMID: 17918191]